Article Details

Arbutus Biopharma, Vaccitech Team Up To Develop Combo Treatment For Hepatitis B

Retrieved on: 2021-07-06 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

Arbutus Biopharma, Vaccitech Team Up To Develop Combo Treatment For Hepatitis B. View article details on hiswai:

Excerpt

Arbutus Biopharma Corporation (NASDAQ: ABUS) and Vaccitech plc (NASDAQ: VACC) have collaborated to evaluate combination treatment for ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up